Qube Research & Technologies (QRT)
FBIO icon

Qube Research & Technologies (QRT)’s Fortress Biotech FBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$3 – 3539
2024
Q2 		$3 Hold
2
– – ﹤0.01% 3672
2024
Q1 		$4 Hold
2
– – ﹤0.01% 4339
2023
Q4 		$6 Sell
2
-1
-33% -$3 ﹤0.01% 4195
2023
Q3 		$12 Buy
+3
New +$21 ﹤0.01% 3914
2022
Q4 		– Sell
-3,774
Closed -$49K – 2626
2022
Q3 		$49K Sell
3,774
-534
-12% -$8K ﹤0.01% 2137
2022
Q2 		$54K Buy
+4,308
New +$63.8K ﹤0.01% 2103
2020
Q2 		– Sell
-12,895
Closed -$366K – 1788
2020
Q1 		$366K Buy
12,895
+3,722
+41% +$124K 0.02% 679
2019
Q4 		$354K Buy
+9,173
New +$236K 0.01% 1137

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FBIO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Fortress Biotech (FBIO) in Q3 2024, closing a stake of 2 shares — an estimated $3 sold.

Qube Research & Technologies (QRT) first reported a position in FBIO in Q4 2019 and held it in 8 quarters. The position peaked at $366K in Q1 2020. 50 funds tracked by Wall St. Rank hold FBIO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Fortress Biotech position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2 Fortress Biotech shares in Q3 2024, an estimated $3.
  • Qube Research & Technologies (QRT) first reported a position in Fortress Biotech in Q4 2019 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Fortress Biotech position peaked at $366K in Q1 2020.
  • 50 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.